Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism
Authors
Keywords
-
Journal
JOURNAL OF VETERINARY INTERNAL MEDICINE
Volume 31, Issue 2, Pages 355-364
Publisher
Wiley
Online
2017-02-01
DOI
10.1111/jvim.14662
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HISTORICAL RESPONSE RATES OF SOMATOSTATIN ANALOGUES IN THE TREATMENT OF ACROMEGALY: A SYSTEMATIC REVIEW
- (2016) Michael H. Shanik et al. Endocrine Practice
- Evaluation of insulin-like growth factor-1, total thyroxine, feline pancreas-specific lipase and urinary corticoid-to-creatinine ratio in cats with diabetes mellitus in Switzerland and the Netherlands
- (2016) Sandra Schaefer et al. JOURNAL OF FELINE MEDICINE AND SURGERY
- Pasireotide for the Medical Management of Feline Hypersomatotropism
- (2015) C.J. Scudder et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly
- (2015) Annamaria Colao et al. Pituitary
- Studying Cat (Felis catus) Diabetes: Beware of the Acromegalic Imposter
- (2015) Stijn J. M. Niessen et al. PLoS One
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pharmacokinetics, pharmacodynamics, and safety of pasireotide LAR in patients with acromegaly: A randomized, multicenter, open-label, phase I study
- (2014) Stephan Petersenn et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Echocardiographic Findings in 11 Cats with Acromegaly
- (2014) J.A. Myers et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
- (2014) Mônica R Gadelha et al. Lancet Diabetes & Endocrinology
- Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
- (2013) Robert R. Henry et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Computed tomographic signs of acromegaly in 68 diabetic cats with hypersomatotropism
- (2013) Christopher R Lamb et al. JOURNAL OF FELINE MEDICINE AND SURGERY
- Hypersomatotropism, Acromegaly, and Hyperadrenocorticism and Feline Diabetes Mellitus
- (2013) Stijn J.M. Niessen et al. VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE
- Ultrasonographic appearance of adrenal glands in healthy and sick cats
- (2012) Anaïs Combes et al. JOURNAL OF FELINE MEDICINE AND SURGERY
- Successful Treatment of Acromegaly in a Diabetic Cat with Transsphenoidal Hypophysectomy
- (2010) Björn P Meij et al. JOURNAL OF FELINE MEDICINE AND SURGERY
- Medical Therapy of Acromegaly
- (2009) Richard A. Feelders et al. DRUGS
- Exogenous Insulin Treatment after Hypofractionated Radiotherapy in Cats with Diabetes Mellitus and Acromegaly
- (2009) M.D. Dunning et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Growth hormone excess and the effect of octreotide in cats with diabetes mellitus
- (2008) L.I. Slingerland et al. DOMESTIC ANIMAL ENDOCRINOLOGY
- Expression of vascular endothelial growth factor in growth hormone-secreting pituitary adenomas: special reference to the octreotide treatment
- (2008) Masamichi Kurosaki et al. NEUROLOGICAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started